Coagulopathies and Thrombosis: Usual and Unusual Causes and Associations, Part III

Emmanuel J Favaloro; Giuseppe Lippi; Massimo Franchini

doi:10.1055/s-0030-1248719

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2010; 36(1): 001-005
DOI: 10.1055/s-0030-1248719

PREFACE

Coagulopathies and Thrombosis: Usual and Unusual Causes and Associations, Part III

Emmanuel J. Favaloro¹ , Giuseppe Lippi² , Massimo Franchini³

¹Department of Haematology, ICPMR, Westmead Hospital, Westmead, NSW Australia
²Sezione di Chimica Clinica, Università di Verona, Verona, Italy
³Immunohematology and Transfusion Center, Department of Pathology and Laboratory Medicine, University Hospital of Parma, Parma, Italy

Abstract

Full Text

References

REFERENCES

1 Franchini M, Lippi G, Favaloro E J. Coagulopathies and thrombosis: usual and unusual causes and associations, Part I. Semin Thromb Hemost. 2009; 35 257-259
2 Lippi G, Franchini M, Favaloro E J. Coagulopathies and thrombosis: usual and unusual causes and associations, Part II. Semin Thromb Hemost. 2009; 35 591-596
3 Montagnana M, Favaloro E J, Franchini M, Guidi G C, Lippi G. The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis. 2009; , June 18 (Epub ahead of print)
4 Heit J A, Silverstein M D, Mohr D N et al.. The epidemiology of venous thromboembolism in the community. Thromb Haemost. 2001; 86 452-463
5 Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost. 2008; 34 747-761
6 de Moerloose P, Neerman-Arbez M. Congenital fibrinogen disorders. Semin Thromb Hemost. 2009; 35(4) 356-366
7 Karimi M, Bereczky Z, Cohan N, Muszbek L. Factor XIII deficiency. Semin Thromb Hemost. 2009; 35(4) 426-438
8 Lippi G, Plebani M. Rapid diagnosis of swine-origin influenza A (H1N1) virus (S-OIV): useful or hype?. Clin Chem Lab Med. 2010; 48(1) 1-5
9 Lippi G, Franchini M, Favaloro E J. Unsuspected triggers of venous thromboembolism—trivial or not so trivial?. Semin Thromb Hemost. 2009; 35 597-604
10 Franchini M, Montagnana M, Targher G, Lippi G. Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseases. Semin Thromb Hemost. 2007; 33 787-797
11 Franchini M, Lippi G. Together we care: new challenges for global haemophilia treatment centers. Indian J Med Res. 2009; 129 345-347
12 Pengo V. Management of oral anticoagulant treatment in patients with venous thromboembolism. Semin Thromb Hemost. 2006; 32 781-786
13 Sobieraj-Teague M, O'Donnell M, Eikelboom J. New anticoagulants for atrial fibrillation. Semin Thromb Hemost. 2009; 35 515-524
14 Levi M, Hobbs F D, Jacobson A K et al.. Improving antithrombotic management in patients with atrial fibrillation: current status and perspectives. Semin Thromb Hemost. 2009; 35 527-542
15 Harenberg J. New anticoagulants in atrial fibrillation. Semin Thromb Hemost. 2009; 35 574-585
16 Harenberg J. Development of new anticoagulants: present and future. Semin Thromb Hemost. 2008; 34 779-793
17 Harenberg J, Wehling M. Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa. Semin Thromb Hemost. 2008; 34 39-57
18 Mousa S A. Heparin, low molecular weight heparin, and derivatives in thrombosis, angiogenesis, and inflammation: emerging links. Semin Thromb Hemost. 2007; 33 524-533
19 Laux V, Perzborn E, Kubitza D et al.. Preclinical and clinical characteristics of rivaroxaban: a novel, oral, direct factor Xa inhibitor. Semin Thromb Hemost. 2007; 33 515-523
20 Prandoni P, Lensing A W, Pesavento R. New strategies for the treatment of acute venous thromboembolism. Semin Thromb Hemost. 2006; 32 787-792
21 Fareed J, Hoppensteadt D A, Fareed D et al.. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Semin Thromb Hemost. 2008; 34 58-73
22 Franchini M, Lippi G. Antagonists of activated factor X and thrombin: innovative antithrombotic agents. Curr Vasc Pharmacol. 2007; 5 121-128
23 Mariani G, Bernardi F. Factor VII deficiency. Semin Thromb Hemost. 2009; 35 400-406
24 Lippi G, Montagnana M, Salvagno G L, Poli G, Franchini M, Guidi G C. Influence of warfarin therapy on activated factor VII clotting activity. Blood Coagul Fibrinolysis. 2006; 17 221-224